Prior studies have reported higher in-hospital survival with prompt defibrillation and epinephrine treatment in patients with inhospital cardiac arrest (IHCA). Whether this survival benefit persists after discharge is unknown.
I
n-hospital cardiac arrest (IHCA) affects 200 000 patients in the United States annually and has significant morbidity and mortality.
1, 2 In shockable rhythms secondary to pulseless ventricular tachycardia (VT) or ventricular fibrillation (VF), prompt defibrillation (≤2 minutes) is associated with higher rates of survival to discharge compared with delayed defibrillation. 3 Similarly, early administration of epinephrine in nonshockable arrests caused by asystole or pulseless electric activity (PEA) is associated with greater odds of survival to discharge. 4 Consequently, clinical guidelines recommend prompt defibrillation for all patients with cardiac arrest presenting with shockable rhythms and epinephrine administration within 3 to 5 minutes for those presenting with nonshockable rhythms. 5, 6 However, prior studies have focused only on in-hospital survival. Whether these process measures are associated with long-term survival is largely unknown but important to understand because the survival advantage with prompt defibrillation or epinephrine treatment may attenuate over time. This is especially important for patients with IHCAs resulting from nonshockable rhythms because these rhythms make up >75% of all IHCAs but have in-hospital survival rates of only 15%. 2 To better understand the impact of these process measures on long-term outcomes, we leveraged data from a large national registry of patients with IHCA linked with Medicare inpatient claims files to examine long-term survival according to the promptness of defibrillation and epinephrine administration in patients with an IHCA resulting from shockable and nonshockable rhythms, respectively. Quantifying the long-term survival benefit associated with timely defibrillation and epinephrine administration can provide important insights into the durability of survival benefits for 2 process-of-care measures in current resuscitation guidelines.
METHODS
The data, analytical methods, and study materials will be made available to other researchers for purposes of reproducing the results once required permission is obtained from the Get With The Guidelines (GWTG)-Resuscitation registry.
Data Sources and Linkage
We used data from American Heart Association's GWTGResuscitation registry, which is a large, prospective, qualityimprovement registry of IHCAs. The design of this registry has been described in detail previously. 7 Briefly, all patients with an IHCA, defined as absence of a palpable central pulse, apnea, and unresponsiveness and without do-notresuscitate orders, are enrolled by trained personnel at participating hospitals. Multiple case-finding methods are used, including centralized collection of cardiac arrest flow sheets, reviews of hospital paging system logs, routine checks of code carts, pharmacy tracer drug records, and hospital billing charges for resuscitation medications. 7 The data are entered into a secured electronic database, which uses standardized definitions for patient variables and outcomes based on Utstein-style templates for reporting cardiac arrest data. 8, 9 To ensure accuracy and completeness of the data, further measures are undertaken that include rigorous certification of hospital staff, use of standardized software with internal checks, and periodic reabstraction and audits of collected data. 7 To obtain information on long-term survival, we used data that have been previously linked with the use of a deterministic algorithm between GWTG-Resuscitation and Medicare inpatient files. 10 Briefly, patient-level data from GWTGResuscitation were linked to Medicare inpatient files using 6 identifiers: the dates of hospital admission and discharge, the patient's age and sex, the admitting hospital (deidentified), and the diagnosis and procedure codes in the International Classification of Diseases, Ninth Revision, Clinical Modification related to cardiac arrest and resuscitation procedures. 10, 11 For each linked patient, Medicare denominator files from 2000 through 2012 were obtained.
Study Population
Because we were interested in examining long-term survival, the study cohort included 162 831 IHCA events in adult patients from 517 hospitals within GWTG-Resuscitation between January 1, 2000, and December 31, 2011, to allow at least 1 year of long-term follow-up (Figure 1 ). We excluded 70 444 IHCA events occurring in patients <65 years of age,
Clinical Perspective
What Is New?
• In a large, national registry of patients with in-hospital cardiac arrest, we found that prompt defibrillation (within 2 minutes) for shockable in-hospital cardiac arrests was associated with a 49% greater likelihood of survival at 1 year, a benefit that persisted at 3 and 5 years.
• Prompt epinephrine treatment (within 5 minutes)
for nonshockable in-hospital cardiac arrests was associated with a 20% greater survival at 1 year but was not sustained at 3 or 5 years of follow-up.
What Are the Clinical Implications?
• These findings provide important insights into the durability of associations with greater survival for 2 process-of-care measures in current resuscitation guidelines.
• Although causal conclusions cannot be drawn from observed associations, early defibrillation and epinephrine administration might have contributed to improved long-term survival in patients with inhospital cardiac arrest.
• These findings underscore the importance of largescale implementation of programs to reduce delays in treatment during acute resuscitation. 
Independent Variable and Outcomes
The primary independent variable was prompt versus delayed treatment for IHCA. Treatment times for defibrillation and epinephrine are documented at the minute level within GWTGResuscitation. For patients with a shockable IHCA caused by VF/VT, prompt treatment was defined as the time from initial arrest to first defibrillation of ≤2 minutes. 3 For patients with a nonshockable IHCA resulting from asystole/PEA, prompt treatment was defined as the time from initial arrest to first epinephrine administration of ≤5 minutes. 6 The primary outcomes of interest were survival at 1, 3, and 5 years from the index IHCA, which was determined from 
Statistical Analysis
Baseline characteristics between patients with prompt and delayed treatment for each rhythm type (shockable, nonshockable) were compared by use of the Student t test or Mann-Whitney U test for continuous variables and the χ 2 or Fisher exact test for categorical variables. Survival curves with Kaplan-Meier estimates were then constructed for each rhythm type to examine unadjusted rates of survival.
To assess the associations between prompt treatment and long-term survival for each rhythm type, hierarchical multivariable modified Poisson regression models were constructed. [12] [13] [14] We used modified Poisson regression to correct for overestimation of estimates of effect observed with odds ratios when the outcome rate exceeds 10%. 15 Instead, Poisson models yield relative risk estimates obtained from a Poisson distribution. [12] [13] [14] Moreover, our models were hierarchical models, with site as a random effect and patientlevel factors as fixed effects. Specifically, they modeled as fixed effects age, sex, race, time to start of cardiopulmonary resuscitation, location of cardiac arrest, and the following coexisting conditions and events present within 24 hours before the cardiac arrest: heart failure, myocardial infarction, diabetes mellitus, renal insufficiency, hepatic insufficiency, respiratory insufficiency, acute stroke, pneumonia, hypotension, sepsis, major trauma, metabolic or electrolyte abnormality, metastatic or hematologic malignancy, and presence of an implantable cardioverter-defibrillator. In addition, the models were adjusted for interventions in place at the time of cardiac arrest (mechanical ventilation, continuous intravenous vasopressor, and hemodialysis), the time of day (daytime [7 am-10:59 pm] versus nighttime [11 
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pm-6:59 am]) and day of the week (weekday versus weekend; weekend versus holiday) of the cardiac arrest, and calendar year of admission (to account for temporal trends). In effect, use of hierarchical models facilitated within-hospital comparisons of patients with early and delayed treatment.
Model performance was assessed with the c statistic. To further examine the effect of time to treatment and survival, we conducted sensitivity analyses wherein times to defibrillation were categorized as ≤1, 2, and >2 minutes and times to epinephrine were categorized as ≤3, 4 to 5, and >5 minutes. All study analyses were performed with SAS 9.4 (SAS Institute, Cary, NC) and R version 2.15.0. 16 All analyses were evaluated with a 2-sided significance level of 0.05. The institutional review board at Saint Luke's Mid America Heart Institute approved the study, deemed it exempt from further review, and waived the requirement for informed consent because the study involved deidentified data.
RESULTS
Of 36 961 patients with an IHCA, 8119 (22.0%) had an initial cardiac arrest rhythm that was shockable, and 28 842 (78.0%) had a nonshockable cardiac arrest rhythm. Among patients with a shockable IHCA, 2959 (36.4%) had an initial cardiac arrest rhythm of pulseless VT, and 5160 (63.6%) had VF. Median time to defibrillation was 1.0 minute (interquartile range, 0.0-3.0 minutes), and 5714 patients (70.4%) received prompt defibrillation (≤2 minutes), whereas 2405 (29.6%) received delayed defibrillation (>2 minutes). Patients with prompt defibrillation were younger and more likely to have an IHCA in intensive care units and during daytime hours, to have a myocardial infarction during the index hospitalization, and to have respiratory insufficiency and hypotension and be on mechanical ventilation or continuous intravenous vasopressor at the time of cardiac arrest (Table 1) .
Among patients with a nonshockable IHCA, 13 746 (47.7%) had an initial rhythm of asystole and 15 096 (52.3%) had PEA. Median time to epinephrine administration was 2.0 minutes (interquartile range, 0.0-4.0 minutes). A total of 24 885 patients (86.3%) received prompt epinephrine treatment (≤5 minutes) compared with 3957 (13.7%) with delayed (>5 minutes) epinephrine treatment. Patients with prompt epinephrine treatment were younger, were more likely to arrest in intensive care units and during daytime hours, and were more likely to have a myocardial infarction during the hospitalization, as well as renal insufficiency, respiratory insufficiency, sepsis, and metabolic and electrolyte abnormalities at the time of their cardiac arrest ( Table 2) .
Rates of prompt defibrillation and prompt epinephrine treatment increased over the study period from 65% to 75% and 81% to 90%, respectively (P for trend for both <0.001; Table I in the online-only Data Supplement).
Survival to Discharge
Prompt defibrillation and epinephrine administration in shockable and nonshockable IHCA, respectively, were associated with greater unadjusted rates of return to spontaneous circulation, 24-hour survival, survival to discharge with good neurological status, and overall survival to discharge compared with delayed treatment, with a larger magnitude of differences between prompt and delayed defibrillation in shockable IHCA than between prompt and delayed epinephrine administration in nonshockable IHCA (Table 3) .
Long-Term Survival
Among patients with a shockable IHCA, 1839 (22.7%) were alive at 1 year, and 1205 (16.8%) and 742 (12.8%) were alive at 3 and 5 years, respectively. Kaplan-Meier survival curves, stratified by the promptness of defibrillation, are displayed in Figure 2 . Patients with prompt defibrillation had a higher unadjusted rate of 1-year survival compared with those with delayed defibrillation (25 (Table 4 ). The C statistic of the adjusted models ranged from 0.75 to 0.79 for the 3 survival time points. Sensitivity analyses show a graded increase in long-term survival with decreasing time to defibrillation, with survival benefits associated with time to defibrillation of ≤1 and 2 compared with >2 minutes extending to 5 years of followup (Table 5 ). Long-term survival with prompt defibrillation in shockable IHCA was not different by location of IHCA (Table II in Among patients with a nonshockable IHCA, 1509 (5.2%) were alive at 1 year, 833 (3.4%) at 3 years, and 434 (2.3%) at 5 years. Kaplan-Meier survival curves for these patients, stratified by promptness of epinephrine treatment, are displayed in Figure 3 . Patients with prompt epinephrine treatment had a higher rate of 1-year survival compared with those with delayed treatment (5 Table 4 ). The C statistic of the adjusted models ranged from 0.73 to 0.78 for the 3 survival time points. In sensitivity analyses, only times to epinephrine of ≤3 minutes were associated with a higher likelihood of 1-year survival (adjusted RR, 1.27; 95% CI, 1.07-1.50; P=0.006), and there were no significant differences in survival at 3 or 5 years in comparisons of times to epinephrine of ≤3, 4 to 5, and >5 minutes (Table 5 ). Long-term survival with prompt epinephrine in nonshockable IHCA was not different by location of IHCA (Table II in 
DISCUSSION
In this large, multicenter national registry of IHCA, we found that patients with shockable arrests caused by VT or VF who received prompt defibrillation had a 53% greater likelihood of survival at 1 year, a benefit that was sustained through 5 years of follow-up. Furthermore, there was a graded inverse association between times to defibrillation and long-term survival. For patients with nonshockable arrests caused 
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by asystole or PEA, long-term survival was low overall (with only 5.2% alive at 1 year and 2.3% at 5 years), and prompt epinephrine administration was associated with improved survival only at 1 year, not at 3 and 5 years. Collectively, our study findings provide important insights into the durability of survival benefits observed during the index hospitalization when patients with IHCA are treated with prompt defibrillation or epinephrine. Single-center studies in patients with shockable arrests have previously reported a strong inverse relationship between time to defibrillation and survival to discharge, but these studies were limited by small numbers and did not examine long-term survival. [17] [18] [19] Similarly, a prior GWTG-Resuscitation analysis of 6789 patients reported a 2.08-times greater odds of inhospital survival with prompt defibrillation compared with delayed defibrillation in patients with a shockable IHCA. 3 However, the association between prompt defibrillation and long-term survival for patients with IHCA is unknown, which has limited our understanding of the survival implications of this resuscitation process measure. Leveraging linked data between a national IHCA registry and Medicare files, we found that prompt defibrillation was associated with an 8% to 10% higher rate of unadjusted absolute survival and a >50% greater likelihood of survival after adjustment that was consistent throughout 5 years of follow-up.
Early defibrillation is associated with shorter duration of arrests, and prior work has shown that it is associated with improved neurological and functional outcomes on discharge. 3 Improved neurological outcomes and consequently better cerebral performance category scores on discharge are also associated with improved 10 Higher rates of survival on discharge with good neurological status with early defibrillation in patients with shockable IHCA might be the potential downstream mechanism explaining improved long-term survival with this process measure. Although decreasing time to administration of epinephrine has also been emphasized in resuscitation guidelines, the long-term survival implication of this resuscitation process measure also has not been well understood. For out-of-hospital cardiac arrests, shorter times to epinephrine are associated with higher rates of return to spontaneous circulation 20, 21 but not survival. 20 Patients with nonshockable IHCAs have low rates of in-hospital and long-term survival, 2,10,22 and our study found overall 1-year survival rates of only 5.2%. Hence, there is great interest in identifying process measures that could improve survival for patients with nonshockable cardiac arrests. Although a previous GWTG-Resuscitation analysis found that patients with faster times to epinephrine had higher rates of in-hospital survival, 4 there is evidence of hospital-level variability in times to epinephrine administrations, with >1 in 10 patients receiving epinephrine after 5 minutes of IHCA. 23 Our study suggests that the survival benefit associated with prompt times to epinephrine extends up to a year after an IHCA and appears localized in those patients treated within the first 3 minutes. However, this survival benefit was not sustained at 3 and 5 years of follow-up, thus underscoring the continued need to identify resuscitation strategies that have durable longterm survival benefits in patients with IHCA caused by asystole and PEA. The lack of significant difference in survival at 3 and 5 years between patients receiving prompt and delayed epinephrine in nonshockable IHCA is likely the result of the small differences in absolute survival at 1 year of follow-up. The absolute differences in survival at 1, 3, and 5 years between prompt and delayed epinephrine administration groups in nonshockable arrests were 1.2%, 0.6%, and 0.4%, respectively, whereas the absolute differences in survival for patients 
with prompt and delayed defibrillation for VT/VF arrests were 10.2%, 8.1%, and 6.8%, respectively. The recent Institute of Medicine report emphasized an urgency for new research to identify effective cardiac arrest treatment strategies that could be efficiently translated into care delivery to achieve better patient outcomes. 24 Our results suggest that efforts to target reduction of times to defibrillation in shockable arrests can potentially achieve large benefits in survival, both short term and long term. These measures may include training nurses who are not certified in acute cardiac life support to defibrillate, increasing access to defibrillation devices in nonmonitored hospital areas, identifying obstacles in achieving prompt times to defibrillation, and providing routine feedback to hospital staff on their times to defibrillation. There is some evidence from singlecenter experiences in the United States and Germany of increased in-hospital survival in patients with IHCA after implementation of hospital-wide programs encouraging early defibrillation, a benefit achieved mainly as a result of improvement in survival of VT/ VF arrests. 25, 26 The findings from this study underscore the potential for large-scale implementation of programs to reduce delays in defibrillation treatment because they may improve both short-and long-term survival in patients with IHCA.
Our study should be interpreted in context of the following limitations. Our study was observational in nature, and the possibility for unmeasured confounding remains, despite adjustment for a number of demographic, comorbidity, and cardiac arrest characteristics. In addition, we could not account for care received by patients during follow-up, which could also affect their long-term survival. It is possible that the survival benefits associated with prompt defibrillation and epinephrine treatment are not causal and reflect unmeasured aspects of cardiopulmonary resus- Tables 1 and 2 Tables 1 and 2 citation quality that correlated strongly with prompt treatment times. Therefore, hospitals should work toward improving the totality of acute resuscitation care, including the provision of high-quality chest compressions with minimal interruptions. Second, our study included only data from hospitals voluntarily participating in the GWTG-Resuscitation registry, so our results might not be generalizable to nonparticipating hospitals. Nonetheless, GWTG-Resuscitation includes information submitted by >500 different large and small hospitals, and there is no reason to expect that the association between prompt versus delayed treatment and survival would differ in nonparticipating hospitals. We also excluded patients <65 years of age because long-term outcomes were not available for these patients, which could affect the generalizability of our findings to younger patients. Among Medicare-eligible patients, 29 013 patients were excluded because of an inability to link patients in GWTG-Resuscitation with Medicare inpatient files. From our prior work, common reasons for nonlinkage included 10 admission to a non-Medicare hospital such as Veteran's Administration hospitals, lack of fee-forservice Medicare insurance, very low number of patients with IHCA enrolled from a particular hospital to facilitate a conclusive linkage, or lack of qualifying International Classification of Diseases, Ninth Revision diagnoses or procedure codes for cardiac arrest in Medicare files to complete linkage. Exclusion of these patients, however, was unlikely to cause significant bias to the results because most patient characteristics were similar in both groups (Table III in the online-only Data Supplement). Similarly, patient characteristics of those with nonshockable IHCA excluded secondary to missing time to epinephrine administration were also similar to those of the final patient cohort. Because treatment received in an index IHCA event would influence subsequent outcomes, for patients with recurrent arrests, we included only the index arrest events. Furthermore, we were unable to assess the impact of prompt treatment on cardiovascular cause of death because neither GWTG-Resuscitation nor Medicare inpatient files collect information on cause of death. Finally, times to treatment were based on reported times of cardiac arrest, defibrillation, and epinephrine administration recorded in patient charts, and there is the possibility of inaccurate documentations of times. Any misclassification in times would be expected to be nondifferential and would have biased our results toward the null, which could have affected our analyses of epinephrine treatment.
CONCLUSIONS
We found that prompt defibrillation was associated with substantially higher survival at 5 years for patients with a shockable IHCA, with a graded inverse relationship between treatment time and survival. Prompt epinephrine administration in nonshockable IHCAs was associated with higher survival at 1 year, but this survival advantage did not persist at 3 and 5 years. By quantifying the greater long-term survival associated with timely defibrillation and epinephrine administration, these findings provide important insights into the durability of survival benefits for 2 process-of-care measures in current resuscitation guidelines. 
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